1. Home
  2. LEXX vs LEE Comparison

LEXX vs LEE Comparison

Compare LEXX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.65

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$4.58

Market Cap

22.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
LEE
Founded
2004
1890
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
22.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEXX
LEE
Price
$0.65
$4.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
1.5M
81.3K
Earning Date
01-13-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
$562,341,000.00
Revenue This Year
$13.35
$5.48
Revenue Next Year
$78.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
N/A
52 Week Low
$0.46
$3.34
52 Week High
$2.43
$15.15

Technical Indicators

Market Signals
Indicator
LEXX
LEE
Relative Strength Index (RSI) 38.76 60.15
Support Level $0.46 $3.58
Resistance Level $0.64 $5.72
Average True Range (ATR) 0.12 0.45
MACD -0.02 0.13
Stochastic Oscillator 17.90 52.52

Price Performance

Historical Comparison
LEXX
LEE

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: